TTM Technologies Reports Strong Q2, Exceeds Revenue Expectations, and Provides Optimistic Guidance for Next Quarter

TTM Technologies reported Q2 CY2025 results with sales up 20.7% YoY to $730.6 million, beating market expectations. Next quarter's revenue guidance of $710 million is 5.6% above analyst estimates. Non-GAAP profit of $0.58 per share is 11% above consensus estimates. CEO Tom Edman attributed the strong results to demand strength in various end markets, including aerospace and defense, medical, and data center computing.

TTM Technologies (TTM) has reported its Q2 CY2025 financial results, showcasing a robust performance that exceeded market expectations. The company's net sales increased by 21% year-over-year (YoY) to $730.6 million, surpassing the consensus estimate of $668.5 million [1]. This impressive growth was driven by strong demand in various end markets, including aerospace and defense, medical, industrial and instrumentation, data center computing, and networking.

The company's non-GAAP earnings per share (EPS) reached a record $0.58, which was 11% above the consensus estimate. CEO Tom Edman attributed the strong results to the demand strength in these key markets. Additionally, the company's strategic acquisitions, such as the acquisition of a facility in Wisconsin and land rights in Penang, are expected to support regional diversification and growth.

For the upcoming Q3 2025, TTM expects its revenue to be between $690 million and $730 million, which is 5.6% above the average analyst estimate of $710 million [1]. The company also expects its non-GAAP EPS for Q3 2025 to be between $0.57 and $0.63, which is in line with the consensus estimate.

The stock recently traded at 22 times the next 12-month earnings, compared to a P/E of 10 three months ago, reflecting the market's optimism about the company's future prospects. The current average analyst rating on the shares is "buy," with a breakdown of recommendations being 4 "strong buy" or "buy," no "hold," and no "sell" or "strong sell" [1].

In contrast, Teradyne (NASDAQ:TER), a semiconductor testing company, reported mixed Q2 CY2025 results. While it met Wall Street’s revenue expectations, its revenue guidance for the next quarter missed analysts’ estimates. However, Teradyne's non-GAAP profit per share beat analysts’ consensus estimates by 4.9% [2].

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_PLX0AAF19:0-ttm-technologies-q2-sales-beat-estimates/
[2] https://www.barchart.com/story/news/33726172/no-surprises-in-teradynes-nasdaqter-q2-sales-numbers-but-quarterly-revenue-guidance-misses-expectations